KR101668447B1 - Composition for curing hanover and health functional foods composition comprising the same - Google Patents

Composition for curing hanover and health functional foods composition comprising the same Download PDF

Info

Publication number
KR101668447B1
KR101668447B1 KR1020090022588A KR20090022588A KR101668447B1 KR 101668447 B1 KR101668447 B1 KR 101668447B1 KR 1020090022588 A KR1020090022588 A KR 1020090022588A KR 20090022588 A KR20090022588 A KR 20090022588A KR 101668447 B1 KR101668447 B1 KR 101668447B1
Authority
KR
South Korea
Prior art keywords
composition
red ginseng
extract
mixed
hangover
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020090022588A
Other languages
Korean (ko)
Other versions
KR20100104275A (en
Inventor
조남훈
조시영
윤준원
김완기
이상준
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR1020090022588A priority Critical patent/KR101668447B1/en
Publication of KR20100104275A publication Critical patent/KR20100104275A/en
Application granted granted Critical
Publication of KR101668447B1 publication Critical patent/KR101668447B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 숙취 해소용 조성물 및 이를 포함하는 건강기능 식품에 관한 것으로, 홍삼, 산수유, 오미자 및 토사자의 추출물을 포함하고, 추가로 홍삼칩을 포함할 수 있다.The present invention relates to a composition for relieving hangover and a health functional food containing the same, which comprises extracts of red ginseng, mountainous oil, omija, and ginseng, and further may contain red ginseng chips.

본 발명은 생약 성분을 이용하여 부작용이 없으며, 숙취해소에 우수한 효과를 갖고, 당침된 홍삼칩을 포함함으로써 우수한 섭취 만족도를 제공할 수 있다.INDUSTRIAL APPLICABILITY The present invention has no side effects by using a herbal medicine component, has an excellent effect on hangover resolution, and can be provided with satisfactory intake satisfaction by including a ginger red ginseng chip.

숙취 해소, 섭취, 만족도, 홍삼칩Hangover, intake, satisfaction, red ginseng chip

Description

숙취 해소용 조성물 및 이를 포함하는 건강기능 식품{COMPOSITION FOR CURING HANOVER AND HEALTH FUNCTIONAL FOODS COMPOSITION COMPRISING THE SAME}BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for relieving hangovers,

본 발명은 숙취 해소용 조성물 및 이를 포함하는 건강기능 식품에 관한 것으로, 보다 상세하게는 생약 추출물을 포함하는 숙취 해소용 조성물과 이를 포함하는 건강기능 식품에 관한 것이다.The present invention relates to a composition for relieving hangover and a health functional food containing the same, and more particularly to a composition for relieving hangover comprising a herbal extract and a health functional food containing the same.

현대인들은 각종 스트레스, 운동부족 및 환경 오염 등으로 인한 심장 기능, 간기능 및 위장 기능이 약화되어 쉽게 피로를 느끼게 되며 허약한 체질을 갖는 경우가 많다. 이러한 현실로 인해서 현대인들의 강장 효과나 피로회복을 위한 각종 건강 보조 식품이 인기를 누리고 있다.Modern people suffer from various stresses, lack of exercise, environmental pollution, etc., and heart function, liver function and gastrointestinal function are weakened and easily fatigued and often have fragile constitution. Because of this reality, various health supplements for the effect of tonic and fatigue of modern people are popular.

시중에 다양한 건강 식품이 유통되고 있지만, 그 효과와 섭취 만족도 면에서 두 가지를 모두 만족시키는 제품이 상대적으로 많지 않아, 이에 대한 꾸준한 소비자의 요구가 있어왔다.Although a variety of health foods are distributed in the market, there are relatively few products satisfying both of the effects and the satisfaction of ingestion, and there has been a steady consumer demand for them.

본 발명의 목적은 생약 추출물을 통해 부작용 없이 섭취 만족도가 높은 숙취 해소용 조성물을 제공하고자 하는 것이다.It is an object of the present invention to provide a composition for relieving hangover which is highly satisfactory in ingestion without side effects through herbal medicine extracts.

삭제delete

본 발명의 또 다른 목적은 상기한 바와 같은 조성물을 포함하는 숙취해소용 건강기능 식품을 제공하고자 하는 것이다.It is still another object of the present invention to provide a health functional food for hangover marine products comprising the composition as described above.

상기 목적을 달성하기 위한 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 홍삼, 산수유, 오미자 및 토사자의 추출물을 유효성분으로 포함한다.In order to accomplish the above object, the composition for removing hangover according to one embodiment of the present invention comprises extracts of red ginseng, mountain syrup, omija, and tortoiseshell as an active ingredient.

상기 조성물은 추가로 홍삼칩을 더 포함할 수 있으며, 상기 홍삼칩은 꿀, 올리고당, 포도당 및 과당 중에서 선택된 적어도 하나에 의해 당침된 것일 수 있다.The composition may further include red ginseng chips, and the red ginseng chips may be ginseng by at least one selected from the group consisting of honey, oligosaccharides, glucose and fructose.

상기 조성물은 전체 조성물 100 중량부를 기준으로 상기 홍삼 추출물 0.1 내지 50 중량부, 상기 산수유, 오미자, 및 토사자의 추출물 0.1 내지 50 중량부를 포함할 수 있고, 홍삼칩을 더 포함하는 경우 이를 0.1 내지 50 중량부로 포함할 수 있다.The composition may contain 0.1 to 50 parts by weight of the red ginseng extract, 0.1 to 50 parts by weight of the extract of the vegetable oil, omija and tortoise, based on 100 parts by weight of the total composition, and 0.1 to 50 parts by weight of the red ginseng chip, .

이러한 본 발명의 일 실시예에 따른 조성물은 액상제, 겔제 또는 고제의 제형을 가질 수 있다. The composition according to one embodiment of the present invention may have a liquid formulation, a gel formulation or a solid preparation.

상기 목적을 달성하기 위한 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 홍삼, 산수유, 오미자 및 토사자의 추출물을 유효성분으로 포함한다.In order to accomplish the above object, the composition for removing hangover according to one embodiment of the present invention comprises extracts of red ginseng, mountain syrup, omija, and tortoiseshell as an active ingredient.

삭제delete

본 발명에 따른 숙취 해소용 조성물과 이를 포함하는 건강기능 식품은 생약 성분을 이용하여 부작용이 없으며, 숙취해소에 우수한 효과를 갖고, 당침된 홍삼칩 등을 포함함으로써 우수한 섭취 만족도를 제공한다.The composition for relieving hangover and the health functional food containing the same according to the present invention have no side effects by using herbal medicine components, have an excellent effect on the elimination of hangover, and provide excellent satisfaction of intake by including ginger red ginseng chips and the like.

본 발명의 일 실시예에 따른 숙취 해소용 조성물은 홍삼, 산수유, 오미자 및 토사자와 같은 생약 성분의 추출물을 포함한다.The composition for relieving hangover according to one embodiment of the present invention includes an extract of a herbal medicine component such as red ginseng, marine oil, omija, and tortoise.

본 발명의 일 실시예에 따른 숙취 해소용 조성물에 포함되는 홍삼(Ginseng radix)은 오갈피과(Araliaceae)에 속한 인삼(Panax ginseng C. A. MEYER)의 건조근이다. 홍삼은 인삼을 쪄서 말린 것으로 성미는 달고 조금 쓰며 성질은 평(平)하며 비(脾)와 폐(肺)로 들어가 작용하며 한의학에서 대표적인 보기약으로, 주치효능은 대보원기, 납기평천, 생진지갈하며 중추신경에 대한 진정작용과 흥분작용이 있고 순환계에 작용하여 고혈압이나 동맥경화 예방효과가 있어 강심작용, 항산화작용, 항피로작용, 항방사능 작용과 혈당강하 작용등이 있다. 주요성분으로는 사포닌(saponine: ginsenosides), 파낙시놀(panaxynol), 베타-엘레멘(β-elemene), 말톨(maltol) 등이 있다. 홍삼의 액상 추출액은 빈혈, 당뇨, 불면증, 위염, 혈압이상, 소화불량, 과로 그리고 피로를 치료하는데 사용되어 왔으며 사포닌이라고 하는 여러 가지 트립테르펜 배당체(triterpene glycoside)를 함유하고 있다고 연구되었다(Baranov A.I., J. Ethnopharmacol, 6,339-353, 1982). 또한 홍삼은 항고혈압작용, 강심작용, 진정작용, 최음작용, 노화방지 및 항산화 작용을 포함한 다양한 약리효과를 가지고 있는 것으로 보고되고 있다(Gillis C.N., Biochem. Pharmacol., 54, 1-8, 1997). The ginseng radix contained in the composition for removing hangover according to one embodiment of the present invention is dried ginseng of Panax ginseng CA Meyer belonging to Araliaceae. Red ginseng is steamed dried ginseng. Its taste is slightly worn, its quality is flat, it enters into the spleen and lungs, and it is a typical medicine in oriental medicine. Its efficacy is in Daebo, It has sedative and excitatory effects on the central nervous system. It acts on the circulatory system and has the effect of preventing hypertension or arteriosclerosis. It has the action of arteriosclerosis, antioxidant, anti-fatigue, anti-radioactivity and hypoglycemic action. The major components are saponine (ginsenosides), panaxynol, beta-elemene, and maltol. Liquid extracts of red ginseng have been used to treat anemia, diabetes, insomnia, gastritis, hypertension, dyspepsia, overwork and fatigue, and have been studied to contain various triterpene glycosides called saponins (Baranov AI, J. Ethnopharmacol., 6, 339-353, 1982). In addition, red ginseng has been reported to have a variety of pharmacological effects including antihypertensive, cardiovascular, sedative, aphrodisiac, antioxidant and antioxidant effects (Gillis CN, Biochem. Pharmacol., 54, 1-8, 1997) .

본 발명의 일 실시예에 따른 숙취 해소용 조성물에 포함되는 산수유(Macrocarpium officinale Sieb. et Zucc.)는 다른 나무는 움도 트기 전인 이른 봄에 잎보다 먼저 황금색 꽃이무리 지어 피는 낙엽성 소고목으로 층층나무과(cornaceae)에 속한다. 이러한 산수유 열매는 결정성 유기산, 몰식자산, 사과산, 포도주산 등을 포함하며, 열매 껍질은 이리도이드배당체인 모르로니시드, 로가닌 등을 포함한다. 동의치료에서는 자양 강장약, 수렴약으로 콩팥을 보하며 땀을 자주 흘리고 오줌이 조금씩 자주 나올 때, 허리아픔, 달거리가 고르지 않을 때 사용한다.The Macrocarpium officinale Sieb. Et Zucc. Contained in the composition for relieving the hangover according to one embodiment of the present invention is a deciduous sago tree in which the golden flowers are gathered before the leaves in the early spring, It belongs to the cornaceae. These acidic fruit oils include crystalline organic acids, gallic acid, malic acid, and wine acids, and the fruit shells include iridoid glycosides such as moronide, roganin, and the like. In the case of bronchial asthma treatment, the kidneys are taken with medicinal medicine, astringent medicines, sweating frequently, when urine comes out frequently, back pain, and when the moon is uneven.

본 발명의 일 실시예에 따른 숙취 해소용 조성물의 기본 성분 중의 하나인 오미자(Schisandra chinensis BAILLON)는 목련과에 속하는 낙엽성, 목본식물로서 덩굴성이며 약으로는 그 열매와 씨를 쓴다. 오미자는 시잔드린 (Schizandrin), 고미신(Gomisin), 시트럴(Citral), 알파-이란진(α-Ylangene), 능금산(Matic acid), 구연산(Citric acid) 등을 주성분으로 하며 중추신경 흥분작용, 진해(鎭咳)작용, 거담 작용, 자궁 수축작용, 항균작용, 혈압강하작용, 강심작용, 트란스아미나제(Transaminase) 저하작용 등의 약리작용이 있으며, 특히 구갈(입이 마르는 증상)과 번열(몸에 열이 나고 가슴이 답답한 증상)을 개선하고 육체적 노동으로 오는 피로를 빨리 회복시키며 심장기능을 강화하고, 혈액순환을 개선해 기억력 감퇴나 사고력 둔화를 예방하는 효과가 있다. 또한, 현대의학에서도 오미자는 손상된 간에 작용하여 SGPT를 정상화시키고 간비대증을 감소시키는 작용을 한다는 것이 임상적으로 널리 알려져 있다.Schizandra chinensis BAILLON , one of the basic components of the hangover-relieving composition according to one embodiment of the present invention, is a deciduous, woody plant belonging to Magnoliaceae, and is vine-like, and its fruit and seeds are used as a medicine. The main ingredient of Schizandrin, Gomisin, Citral, α-Ylangene, Matic acid, Citric acid, etc., There is a pharmacological action such as Jinhae (鎭 咳) action, geomorphic action, contraction of the uterus, antibacterial action, hypotensive action, arteriosclerosis action and transaminase lowering action. Especially, (Symptoms of fever and chest tightness in the body), to quickly recover from fatigue caused by physical labor, to strengthen cardiac function, and to improve blood circulation, thereby preventing memory loss or slowing down of thinking ability. Also, in modern medicine, it is clinically well known that Omija functions to normalize SGPT by acting on injured liver and to reduce hepatomegaly.

또한, 본 발명의 일 실시예에 따른 숙취 해소용 조성물의 일성분인 토사자(Cuscuta chinensis Lamak)는 새삼(Cuscuta japonica Choisy)의 씨를 말린 것으로, 프로비타민 A를 약 40㎎%로 함유하고 있으며, 맛은 달고 매우며 성질은 평하다. 주로 간과 신장을 보호하며 눈을 밝게 해주고, 양기를 도우며 신장 기능을 튼튼하게 해주는 약재로 알려져 있다. In addition, Cuscuta chinensis Lamak , a component of the composition for removing hangover according to an embodiment of the present invention, is a dried Cuscuta japonica Choisy seed, which contains about 40 mg% of provitamin A, It is sweet and sweet and the nature is plain. It is known as a medicinal product that mainly protects the liver and kidneys, brightens the eyes, helps the Yangs and strengthens the kidney function.

상기한 바와 같은 홍삼, 산수유, 오미자 및 토사자는 물 또는 C1 내지 C4의 저급 알코올, 예를 들어 에탄올 또는 이들의 혼합물로 추출한 추출물의 형태로 사용된다. 저급 알코올의 경우, 알코올의 농도는 0.1 내지 100%, 바람직하게는 70% 이상이다.The above-mentioned red ginseng, marine oil, omija and algae are used in the form of extracts extracted with water or a C 1 to C 4 lower alcohol such as ethanol or a mixture thereof. In the case of lower alcohols, the concentration of alcohol is 0.1 to 100%, preferably 70% or more.

이때 추출 방법은 열수 추출법, 주정 추출법 등의 통상의 추출법을 이용할 수 있으며, 상술한 각 생약에서 최대한의 유효 성분을 추출할 수 있는 방법이라면 특별히 한정되지는 않는다.The extraction method may be a conventional extraction method such as a hot water extraction method or a sputum extraction method and is not particularly limited as far as it is possible to extract the maximum effective ingredient from each herbal medicine described above.

또한, 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 홍삼칩을 더 포함할 수 있다. 홍삼칩은 홍삼을 잘게 썬 형태로서, 이러한 홍삼칩은 당침 처리된 형태로 사용될 수 있다. 홍삼칩의 당침은 피로회복과 원기개선에 도움을 주는 꿀, 포도당 또는 과당이나, 배변 활동을 원활하게 해주는 예를 들면 이소말토올리고당, 프락토올리고당, 갈락토올리고당, 자일로올리고당, 말토올리고당 등의 올리고당이나, 이들에서 2가지 이상 선택하여 행하여질 수 있다. 상기한 바와 같은 당침된 홍삼칩의 경우, 홍삼 특유의 효능 외에 꿀, 올리고당, 포도당, 과당 특유의 영양 성분에 의한 상승적인 효과를 가질 수 있을 뿐만 아니라, 씹는 감촉과 그 맛에 의해 섭취 만족도를 높일 수 있다.In addition, the composition for removing hangover according to an embodiment of the present invention may further include red ginseng chips. Red ginseng chips are finely divided red ginseng chips, and these red ginseng chips can be used in the form of glycyrrhizin. The gums of red ginseng chips are made of honey, glucose or fructose which helps to regain fatigue and refreshing, but also to facilitate the bowel movement such as isomaltooligosaccharide, fructooligosaccharide, galactooligosaccharide, xyloglucose, maltooligosaccharide Oligosaccharides, or oligosaccharides. In the case of the red ginseng chips as described above, not only the effect specific to red ginseng but also the synergistic effect due to the nutritional ingredients peculiar to honey, oligosaccharide, glucose and fructose, as well as the chewing feeling and the satisfaction of ingestion due to the taste thereof .

상술한 바와 같은 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 전체 조성물 100 중량부를 기준으로 홍삼 추출물을 0.1 내지 50 중량부, 혼합 생약재 추출물을 0.1 내지 50 중량부를 포함할 수 있다.The composition for removing hangover according to one embodiment of the present invention may include 0.1 to 50 parts by weight of red ginseng extract and 0.1 to 50 parts by weight of mixed herbal extract based on 100 parts by weight of the whole composition.

또한, 홍삼칩을 포함하는 경우에는, 0.1 내지 50 중량부의 범위로 포함될 수 있다.In the case of containing red ginseng chips, the content may be in the range of 0.1 to 50 parts by weight.

본 발명의 일 실시예에 따른 숙취 해소용 조성물은 상기 각 성분을 상기한 바와 같은 범위에서 사용할 경우 우수한 간기능 개선 효과와 섭취 만족도를 제공할 수 있다.The composition for removing hangover according to one embodiment of the present invention can provide excellent liver function improving effect and satisfactory intake when each component is used within the above-mentioned range.

또한, 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 및 희석제를 더 포함할 수도 있다. In addition, the composition for removing hangover according to an embodiment of the present invention may further comprise suitable carriers, excipients and diluents conventionally used in the production of the composition.

이러한 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 섭취에 편리한 형태로 다양한 경구 제형을 가질 수 있으며, 예를 들어 액상제, 겔제 또는 고제(膏劑)의 제형을 가질 수 있다. The composition for removing hangover according to one embodiment of the present invention may have various oral formulations in a convenient form for ingestion, and may have formulations of, for example, a liquid preparation, a gel or a gum.

또한, 본 발명의 일 실시예에 따른 숙취 해소용 조성물의 바람직한 섭취량은 신체의 건강 상태, 체중, 질병의 정도 등에 따라 다양하게 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 본 발명의 일 실시예에 따른 숙취 해소용 조성물을 1일 1g 내지 5g으로, 바람직하게는 2g 내지 4g으로 섭취하는 것이 좋다. 투여는 하루에 한번 섭취할 수도 있고, 수회 나누어 섭취할 수도 있다. 상기 투여량은 어떠한 면으로도 본 발명의 범위를 한정하는 것은 아니다.In addition, the preferred amount of the composition for removing hangover according to one embodiment of the present invention may be appropriately selected by those skilled in the art, although it varies depending on the health state of the body, the body weight, the degree of disease, and the like. However, for the desired effect, it is preferable to take the composition for removing hangover according to one embodiment of the present invention at 1 g to 5 g, preferably 2 g to 4 g per day. The administration can be taken once a day, or divided into several times. The dose is not intended to limit the scope of the invention in any way.

상술한 바와 같은 본 발명의 일 실시예에 따른 숙취 해소용 조성물은 숙취해소용 일반 식품이나 건강기능 식품에 포함되어 제공될 수도 있다. 상기 식품의 종류에는 특별한 제한은 없다. 상기 숙취 해소용 조성물을 첨가할 수 있는 식품의 예로는 드링크제, 육류, 소시지, 빵, 비스킷, 떡, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 거류, 아이스크림류를 포함한 낙농 제품, 각종 수프, 음료수, 알코올 음료 및 비타민 복합제 등이 있으며, 통상의 건강식품을 모두 포함한다.The composition for removing hangover according to one embodiment of the present invention as described above may be provided in a general food for hangover, or a health functional food. There is no particular limitation on the kind of the food. Examples of the food to which the hangover-removing composition can be added include dairy products including drinks, meat, sausage, bread, biscuits, rice cakes, chocolates, candies, snacks, confectionery, pizza, ramen noodles, Various soups, beverages, alcoholic beverages, and vitamin complexes, and includes all common healthy foods.

이하, 실험예, 실시예, 비교예에 의하여 본 발명을 더욱 상세하게 설명하고자 한다.  단, 하기 실험예, 실시예, 비교예는 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Experimental Examples, Examples and Comparative Examples. However, the following Experimental Examples, Examples, and Comparative Examples are for illustrative purposes only and are not intended to limit the scope of the present invention.

<실험예><Experimental Example>

1. 각 생약에 대한 추출물 및 홍삼칩의 제조1. Preparation of extracts and red ginseng chips for each herbal medicine

아래와 같이 각각의 추출물을 별도로 제조한 후 혼합하여 본 발명의 일 실시 예에 따른 조성물이 완성될 수 있다.Each of the extracts may be separately prepared and mixed as described below to complete the composition according to one embodiment of the present invention.

1) 홍삼 추출물의 제조1) Preparation of red ginseng extract

① 건강기능식품공전에서 정하는 기준 및 규격에 적합한 4년근 이상의 홍삼에서 이물질을 선별하고 세척한 후, 물과 에탄올을 혼합하여 추출기에 넣고, 65~75℃에서 10~15시간 동안 3~5회 반복하여 홍삼의 유효 성분을 추출하였다.① After selecting and washing the red ginseng for 4 years or more in accordance with the standards and specifications specified in the Health Functional Food Code, water and ethanol are mixed and placed in an extractor and repeated 3-5 times at 65 ~ 75 ℃ for 10 ~ 15 hours And the active ingredient of red ginseng was extracted.

② 추출액을 250 메쉬 여과기로 가압식 여과한 후, 이를 감압 농축기로 옮겨 압력 500~1000 mmHg, 온도 60~80℃에서 농축하여, 60~70 브릭스(brix) 농축액을 얻었다.② The extract was pressure-filtered through a 250-mesh filter, transferred to a vacuum concentrator, and concentrated at a pressure of 500 to 1000 mmHg at a temperature of 60 to 80 ° C. to obtain a concentrated brix of 60 to 70 brix.

2) 산수유, 오미자, 및 토사자의 추출물 제조2) Manufacture of extracts of corn oil, omija, and soil extract

① 품질이 양호하고 정선, 건조된 산수유, 오미자, 토사자를 세척한 후 산수유, 오미자, 토사자의 중량비를 1: 1: 1의 비율로 한 혼합 원료와 정제수의 중량비를 1:8의 비율로 추출기에 넣고 80℃ 이상에서 5~7 시간 동안 추출하여 유효성분을 추출한다.① The quality of the product is good, and the weight ratio of the mixed raw material and purified water in the ratio of 1: 1: 1, weight ratio of corn oil, omija, And extracted at 80 ° C or higher for 5 to 7 hours to extract an active ingredient.

② 추출액을 상온으로 냉각하고, 마이크로 필터(1㎛)를 이용하여 여과한 후, 고형분 함량 50% 이상이 될 때까지 감압 농축한 다음 90℃에서 10~20분간 가열 살균하였다.(2) The extract was cooled to room temperature, filtered using a microfilter (1 μm), concentrated under reduced pressure to a solid content of 50% or more, and then sterilized by heating at 90 ° C. for 10 to 20 minutes.

3) 홍삼칩의 제조3) Manufacture of red ginseng chips

① 인삼산업법에서 규정한 4년근 이상 수삼을 세척하고 협잡물 등 이물 및 병든 부위를 제거 한 후, 파쇄한 다음 70~95℃에서 3~5시간 동안 증숙하였다. ① Wash ginseng for 4 years or more as prescribed by the Ginseng Industrial Act and remove impurities and diseased parts such as impurities, then crush them and then boil them at 70 ~ 95 ℃ for 3-5 hours.

② 증숙이 완료된 수삼과 프락토올리고당을 증삼기에 투입하여 균일하게 혼합한 다음 50~90℃에서 5~10시간 동안 당침하였다.② Fresh ginseng and fructo-oligosaccharide were added to the ginseng, homogenously mixed and then dipped in 50 ~ 90 ℃ for 5 ~ 10 hours.

③ 당침이 완료된 홍삼칩을 수거한 후, 80℃이상에서 2~3시간 동안 살균하였다. ③ Red ginseng chips were collected and sterilized at 80 ℃ for 2 ~ 3 hours.

2. 숙취 해소용 조성물의 제조2. Preparation of composition for removing hangover

홍삼, 산수유, 오미자 및 토사자의 추출물과 선택적으로 홍삼칩을 포함하는 본 발명의 일 실시에에 따른 숙취 해소용 조성물을 하기 표 1과 같은 구성을 갖도록 제조하였다.The composition for removing hangover according to one embodiment of the present invention comprising extracts of red ginseng, corn oil, omija and algae, and optionally red ginseng chips was prepared as shown in Table 1 below.

상기 숙취 해소용 조성물은 겔 타입 제형으로 제조하였다. 구체적으로는 아래와 같다The composition for removing hangover was prepared in a gel type formulation. Specifically, it is as follows

① 원료① raw materials

식품공전, 건강기능식품공전 및 식품첨가물 공전의 기준 규격에 적합한 상기 원료를 국내외에서 구입하여 자체 품질검사를 한 후 사용하였다. The product was purchased from domestic and foreign countries, which were in conformity with the standards of Food Code, Health Function Food Code, and Food Additives Code.

② 칭량② Weighing

품질관리 시험에서 적합한 상기의 원료를 제조지시된 배합비율대로 전자저울을 이용하여 정밀하게 칭량하였다.The raw materials suitable for the quality control test were precisely weighed using an electronic balance at the specified mixing ratio.

③ 혼합③ Mixed

홍삼 추출물, 토사자, 산수유, 및 오미자의 추출물, 홍삼칩, 산탄검, 꿀, 프락토올리고당 등을 첨가하여 교반하면서, 내용물의 온도가 85±5℃로 도달하면 30~60분간 혼합기에서 혼합하여 교반하였다. 산탄검이 충분히 교반되었는지 확인한 다음 작업을 진행하였다. When the temperature of the contents reaches 85 ± 5 ° C while stirring, the mixture is mixed in a mixer for 30 to 60 minutes, and stirred, and the mixture is stirred. Respectively. After confirming that the xanthan gum was sufficiently stirred, the operation was carried out.

④ 공정검사④ Process inspection

pH, 고형분 함량, 점도, 미생물 등을 확인하였다. pH, solids content, viscosity, and microorganism.

⑤ 충진⑤ filling

충진 호퍼 내용물과 충진 직후온도가 85±5℃가 되도록 하여 충진 작업을 실시하고 파우치의 밀봉상태를 확인하였다. Immediately after filling the contents of the filling hopper and the temperature of 85 ± 5 ° C, filling operation was performed and the sealing state of the pouch was confirmed.

3. 비교 조성물의 제조3. Preparation of Comparative Compositions

하기 표 1과 같은 구성을 갖는 비교 조성물을 제조하였다.Comparative compositions having the compositions shown in Table 1 below were prepared.

단위
(중량부)
unit
(Parts by weight)
홍삼 추출물Red ginseng extract 산수유, 오미자,
및 토사자의
추출물
Corn oil, Omija,
And the
extract
홍삼칩Red ginseng chip 산탄검Xanthan gum honey 프락토
올리고당
Fructose
oligosaccharide
정제수Purified water
실시예 1Example 1 1010 1010 00 0.50.5 1010 44.544.5 2525 실시예 2Example 2 1010 1010 1515 0.30.3 1010 44.744.7 1010 비교예 Comparative Example 1010 00 00 0.70.7 1010 44.344.3 3535

4. 혈중 알코올 농도 테스트4. Blood alcohol test

7주령의 무모쥐(hairless mouse) 각각 5마리에 대해 각각 실시예 2의 조성물과 비교예의 조성물을 200mpk 농도로 일일 1회, 5일 동안 경구 투여하였다. For each of five 7-week-old hairless mice, the composition of Example 2 and the composition of Comparative Example were orally administered at a concentration of 200 mpk once a day for 5 days.

5일째에 무모쥐들에 각 시료를 투여하고, 3시간 이후에 20% 에탄올 용액 0.26ml을 투여한 다음, 1시간, 3시간, 5시간 경과 후 부검을 하여 혈액을 채취하였다. 이어, 채취한 혈액에서 혈청을 분리한 후 혈중 알코올 농도를 분석하여 도 1에 나타내었다. On the 5th day, each sample was administered to dull mice. After 3 hours, 0.26 ml of 20% ethanol solution was administered. After 1 hour, 3 hours, and 5 hours, the blood samples were collected by autopsy. Then, serum was separated from collected blood, and blood alcohol concentration was analyzed and shown in FIG.

알코올 분석방법은 아래와 같다The alcohol analysis method is as follows

1) 혈액 내 알코올 함량을 분석하기 위해 사용되는 반응 혼합물(reaction mixture) 3ml(인산칼륨 완충용액 pH 9 + NAD 타블렛(tablet))에 혈액 0.1ml를 혼합하여 샘플을 제조하였다.1) A sample was prepared by mixing 3 ml of the reaction mixture (potassium phosphate buffer solution pH 9 + NAD tablet) used for analyzing the alcohol content in the blood with 0.1 ml of blood.

2) 상기 샘플을 3분 동안 20℃에서 배양하였다.2) The sample was incubated for 3 minutes at 20 &lt; 0 &gt; C.

3) UV 분광기(UV-1601, 시마츠사제)를 이용하여 340nm에서 상기 샘플의 흡광도를 측정(A1)하였다.3) The absorbance of the sample was measured (A1) at 340 nm using a UV spectrometer (UV-1601, manufactured by Shimadzu Corporation).

4) 알코올탈수소효소(alcohol dehydrogenase)를 상기 샘플에 0.05ml 첨가하였다. 4) 0.05 ml of alcohol dehydrogenase was added to the sample.

5) 상기 샘플을 약 5분 동안 20℃에서 배양하였다.5) The sample was incubated at 20 [deg.] C for about 5 minutes.

6) UV 분광기(UV-1601, 시마츠사제)를 이용하여 340nm에서 상기 샘플의 흡광도를 측정(A2) 하였다.6) The absorbance of the sample was measured (A2) at 340 nm using a UV spectrometer (UV-1601, manufactured by Shimadzu Corporation).

7) 상기에서 얻어진 값들은 다음 식에 대입하여 알코올 농도값을 계산하였다.7) The values obtained above were substituted into the following formulas to calculate the alcohol concentration.

알코올 농도= 0.7259/3.6 X △AAlcohol concentration = 0.7259 / 3.6 X DELTA A

△A = 샘플(A2-A1)-블랭크(A2-A1)DELTA A = sample (A2-A1) -blank (A2-A1)

도 1에 도시한 바와 같이, 20% 에탄올 용액을 투여한 후, 1시간 이후 혈중 알코올 농도를 분석한 결과 비교예의 조성물을 투여한 무모쥐들의 경우 평균 약 235mg%이었고, 실시예 2의 조성물을 투여한 무모쥐들의 경우 평균 약 60mg%로, 이들 결과로부터 유의차 있는 효과를 확인할 수 있었으며, 3시간, 5시간에서의 혈중 알코올 농도도 실시예 2와 비교예에서 유의차 있음을 확인할 수 있었다. 따라서, 본 발명의 일 실시예에 따른 조성물에 해당하는 실시예 2의 조성물이 혈중 알코올 농도를 억제하는 효능이 있음을 확인하였다.As shown in FIG. 1, after the administration of the 20% ethanol solution, the concentration of alcohol in the blood after one hour was analyzed. As a result, it was found that the average value of the alcohol concentration in the hairless mice administered with the composition of the comparative example was about 235 mg% The results are shown in Table 2. The results are shown in Table 1. The results are shown in Table 1. The results are shown in Table 1. The results are shown in Table 1. The results are shown in Table 1. Accordingly, it was confirmed that the composition of Example 2 corresponding to the composition according to one embodiment of the present invention has an effect of inhibiting blood alcohol concentration.

4. 숙취 해소 패널 테스트4. Hangover resolution panel test

성인 남녀 10명을 대상으로 음주 후 실시예 2의 조성물과 비교예의 조성물의 액상제를 섭취하게 한 후, 숙취 개선 효능을 설문 조사하였다. After drinking the liquid composition of the composition of Example 2 and the composition of the comparative example, ten adult male and female subjects were questioned about the hangover improvement efficacy.

성인 남녀 10인에게 소주 1병 반에 해당하는 알코올을 섭취하게 한 후, 실시예 2와 비교예의 조성물의 액상제 50ml를 섭취하게 하였다. 섭취 후 5시간이 경과한 다음, 숙취해소에 효과가 있는지에 대한 설문에 대하여 조사한 후, 7점 척도에서 6~7점이면 효과 매우 좋음, 4~5점이면 효과 좋음, 2~3점이면 보통, 1점이면 효과 없음으로 하여 그 결과를 다음 표 2에 정리하였다.Ten adult males and females were allowed to consume alcohol equivalent to one and a half bottle of shochu, followed by ingesting 50 ml of the liquid composition of the composition of Example 2 and the comparative example. After 5 hours of ingestion, the questionnaire survey was conducted to determine whether it was effective in relieving hangovers. After 6 to 7 points, the effect was very good, 4 to 5 points were effective, and 2 to 3 points were effective , And a score of 1 indicates no effect, and the results are summarized in Table 2 below.

효과
매우 좋음
effect
Very good
효과
좋음
effect
good
보통usually 효과
없음
effect
none
실시예 2Example 2 3명3 people 5명5 people 1명1 person 1명1 person 비교예 Comparative Example 0명0 people 2명2 people 4명4 people 4명4 people

상기 표 2의 결과로부터, 본 발명의 일 실시예에 따른 조성물인 실시예 2의 조성물을 섭취할 경우, 비교예 조성물을 섭취한 경우보다 유의차 있게 숙취 개선 효과가 있음을 알 수 있다. From the results shown in Table 2, it can be seen that when the composition of Example 2, which is a composition according to one embodiment of the present invention, is consumed, the hangover improvement effect is significantly higher than that of the composition of Comparative Example.

5. 섭취 만족도 테스트5. Intake Satisfaction Test

성인 남녀 10명을 대상으로 하여, 각각 실시예 1, 2와 비교예의 조성물의 겔제 15g를 섭취하게 한 후, 섭취 만족도를 5점 척도로 조사하여 도 2에 나타냈다.Ten adult males and females received 15 g of the gel formulation of the compositions of Examples 1 and 2 and Comparative Examples, respectively, and the degree of satisfaction with the intake was measured on a 5-point scale and shown in Fig.

도 2에 도시한 바와 같이, 당침된 홍삼칩을 포함하는 실시예 2가 가장 높은 섭취만족도를 제공하였다. 따라서, 본 발명의 일 실시예에 따른 조성물 중 홍삼칩을 포함하는 경우 섭취만족도가 높아짐을 알 수 있다.As shown in Fig. 2, Example 2 including the grated red ginseng chips provided the highest degree of satisfaction with ingestion. Accordingly, it can be seen that the satisfaction of ingestion is increased when the composition according to an embodiment of the present invention includes red ginseng chips.

계속해서, 본 발명에 따른 조성물의 제형예를 설명한다. 하기의 제형예는 본 발명을 어떠한 방법으로도 한정하는 것이 아니며, 단지 구체적으로 설명하고자 함이다.Next, a formulation example of the composition according to the present invention will be described. The following formulation examples are not intended to limit the invention in any way, but merely to illustrate them.

<제형예 1> 액상제&Lt; Formulation Example 1 >

하기 표 3에 기재된 조성에 따라 통상적인 방법으로 액상제를 제조하였다.A liquid agent was prepared by a conventional method according to the composition shown in Table 3 below.

배합 성분Compounding ingredient 배합비(중량부)Mixing ratio (parts by weight) 홍삼 추출물Red ginseng extract 1010 산수유, 오미자, 및 토사자 추출물Corn oil, Omiza, and Tozan extract 1010 홍삼칩Red ginseng chip 1515 honey 1515 프락토올리고당Fructooligosaccharide 1515 구연산Citric acid 0.20.2 정제수Purified water 34.834.8

<제형예 2> 겔제&Lt; Formulation Example 2 >

하기 표 4에 기재된 조성에 따라 통상적인 방법으로 겔제를 제조하였다.A gel was prepared by a conventional method according to the composition shown in Table 4 below.

배합 성분Compounding ingredient 배합비(중량부)Mixing ratio (parts by weight) 홍삼 추출물Red ginseng extract 1515 산수유, 오미자, 및 토사자의 추출물Extract of corn oil, omija, and Tozan 1515 홍삼칩Red ginseng chip 2020 honey 1515 프락토올리고당Fructooligosaccharide 2525 구연산Citric acid 0.20.2 산탄검Xanthan gum 1One 정제수Purified water 8.88.8

<제형예 3> 고제&Lt; Formulation Example 3 >

하기 표 5에 기재된 조성에 따라 통상적인 방법으로 고제를 제조하였다.The compositions were prepared in the usual way according to the compositions shown in Table 5 below.

고제를 제조하는 데 있어, 아래 혼합원료를 5시간 이상 농축한 후 7시간 이상 증숙하여 고제를 제조하였다.In the preparation of the gypsum, the following ingredients were concentrated for more than 5 hours and then mixed for more than 7 hours to prepare a gypsum.

배합 성분Compounding ingredient 배합비(중량부)Mixing ratio (parts by weight) 홍삼 추출물Red ginseng extract 2020 산수유, 오미자, 및 토사자의 추출물Extract of corn oil, omija, and Tozan 2020 honey 2525 프락토올리고당Fructooligosaccharide 33.833.8 구연산Citric acid 0.20.2 산탄검Xanthan gum 1One

도 1은 본 발명의 일 실시예에 따른 조성물인 실시예 2와 비교예의 숙취 해소능을 나타낸 그래프이다.FIG. 1 is a graph showing the hangover resolution performance of Example 2, which is a composition according to an embodiment of the present invention, and Comparative Example. FIG.

도 2는 본 발명의 일 실시예에 따른 조성물들인 실시예 1, 2와 비교예의 섭취 만족도를 나타낸 그래프이다.FIG. 2 is a graph showing satisfaction of ingestion in Examples 1 and 2 and Comparative Examples according to an embodiment of the present invention. FIG.

Claims (8)

홍삼 추출물; 및 산수유, 오미자 및 토사자로 이루어진 혼합 생약재의 추출물; 및 홍삼칩을 유효 성분으로 포함하는, 숙취 해소용 식품 조성물로서,Red ginseng extract; And extracts of mixed herbal medicines consisting of marine oil, omija and algae; And a red ginseng chip as an active ingredient, 상기 홍삼 추출물과 혼합 생약재 추출물은 1:1의 중량비로 혼합되고,The red ginseng extract and the mixed herbal extract were mixed at a weight ratio of 1: 1, 상기 홍삼 추출물은 물과 에탄올의 혼합 용매로 추출하여 수득된 것이며,The red ginseng extract was obtained by extracting with a mixed solvent of water and ethanol, 상기 홍삼 추출물은 조성물 총 중량을 기준으로 10 중량부로 함유되고,The red ginseng extract is contained in an amount of 10 parts by weight based on the total weight of the composition, 상기 혼합 생약재 중의 산수유, 오미자 및 토사자는 1:1:1의 중량비로 혼합되며,The vegetable oil, the omija and the soil in the mixed herbal medicines are mixed at a weight ratio of 1: 1: 1, 상기 혼합 생약재의 추출물은 물로 추출하여 수득된 것이고,The extract of the mixed herb medicine is obtained by extracting with water, 상기 혼합 생약재의 추출물은 조성물 총 중량을 기준으로 10 중량부로 함유되며,The extract of the mixed herb medicine is contained in an amount of 10 parts by weight based on the total weight of the composition, 상기 홍삼칩은 조성물 총 중량을 기준으로 15 중량부로 함유되는 것을 특징으로 하는, 숙취 해소용 식품 조성물.Wherein the red ginseng chips are contained in an amount of 15 parts by weight based on the total weight of the composition. 삭제delete 제 1항에 있어서,The method according to claim 1, 상기 홍삼칩은 꿀, 올리고당, 포도당 및 과당 중에서 선택된 적어도 하나에 의해 당침된 것인, 식품 조성물.Wherein the red ginseng chips are dipped by at least one selected from the group consisting of honey, oligosaccharides, glucose and fructose. 삭제delete 삭제delete 제 1항에 있어서,The method according to claim 1, 상기 조성물은 액상제, 겔제 또는 고제인, 식품 조성물.Wherein the composition is a liquid, gel or solid. 삭제delete 제 1항, 제 3항, 및 제 6항 중 어느 한 항에 따른 숙취 해소용 식품 조성물을 포함하는, 건강기능 식품.A health functional food comprising the food composition for hangover according to any one of claims 1, 3, and 6.
KR1020090022588A 2009-03-17 2009-03-17 Composition for curing hanover and health functional foods composition comprising the same Expired - Fee Related KR101668447B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090022588A KR101668447B1 (en) 2009-03-17 2009-03-17 Composition for curing hanover and health functional foods composition comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090022588A KR101668447B1 (en) 2009-03-17 2009-03-17 Composition for curing hanover and health functional foods composition comprising the same

Publications (2)

Publication Number Publication Date
KR20100104275A KR20100104275A (en) 2010-09-29
KR101668447B1 true KR101668447B1 (en) 2016-10-24

Family

ID=43008543

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090022588A Expired - Fee Related KR101668447B1 (en) 2009-03-17 2009-03-17 Composition for curing hanover and health functional foods composition comprising the same

Country Status (1)

Country Link
KR (1) KR101668447B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103120718B (en) * 2011-11-18 2015-10-14 中国人民解放军第三〇二医院 A kind of pharmaceutical composition for the treatment of chronic hepatitis, liver cirrhosis
WO2021019434A1 (en) * 2019-07-29 2021-02-04 Neilos S.r.l. Composition for use in the prevention and/or treatment of symptoms related to tiredness and fatigue

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543940B1 (en) 2004-11-12 2006-01-20 김길용 Preparation method of red ginseng sliced tablets, and sugar acupuncture used in the preparation of red ginseng sliced tablets and red ginseng sliced tablets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970014582A (en) * 1997-01-18 1997-04-28 이훈석 Manufacturing method of health pledge
KR20030047627A (en) * 2001-12-10 2003-06-18 서봉석 Healthy foods on the topic of Cos Fructus
KR100500521B1 (en) * 2003-08-27 2005-07-18 한국식품연구원 Food composition having preventive effect of alcohol induced fatty liver and solving hang over problems and manufacturing method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100543940B1 (en) 2004-11-12 2006-01-20 김길용 Preparation method of red ginseng sliced tablets, and sugar acupuncture used in the preparation of red ginseng sliced tablets and red ginseng sliced tablets

Also Published As

Publication number Publication date
KR20100104275A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
KR101144920B1 (en) An Extract with Red Ginseng and Herbs
KR20150005430A (en) Composition for relieving premenstrual syndrome and menstrual pain
KR102457306B1 (en) Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same
JP2013203683A (en) Type iii collagen production promotor
KR20100125618A (en) Preparation method of fermented red ginseng beverage mixed with herbal extracts and beverage composition comprising same
KR20140026748A (en) An anti-diabetes composition comprising ginseng radix and mulberry tree extract as effective ingredients
CN1961700B (en) Hard sugar of green tea preparation method
KR101394358B1 (en) Health composition relieving alcohol hangover
KR20150002048A (en) A composition for preventing wrinkle of skin and anti aging of skin
KR101668447B1 (en) Composition for curing hanover and health functional foods composition comprising the same
KR101083524B1 (en) Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup
KR20170077980A (en) Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill.
KR20120122755A (en) Food Composition For Improving Bowel Movement Comprising Functional Food Component As Active Ingredient
KR101935861B1 (en) Functional food composition for removing hangover and improving liver function and manufacturing method for thereof
KR102132537B1 (en) Platycodon grandiflorum Liquid composition for stick-type container having increased ginsenosides of human body absorption type, and preparation method thereof
KR20100094015A (en) Composition for asthma containing black platycodon and phellinus as effective ingredients
KR100815200B1 (en) Red Ginseng Mixture Composition with Anti-obesity Effect
KR101310648B1 (en) Composition comprising leaves of peucedanum japonicum for relieving hangover or fermented liquor having leaves of peucedanum japonicum
KR101034986B1 (en) Hangover relief composition containing mixed herbal extracts as an active ingredient
EP1718167A1 (en) Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof
KR20170086198A (en) Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby
KR20070101441A (en) Liver function improvement composition containing mixed herbal extract as active ingredient
KR20200117184A (en) Composition of health functional food containing an active ingredient of mixed vegetable powder with enhanced immunity activity
KR100586269B1 (en) Composition containing ginger tree extract as an active ingredient
KR102153830B1 (en) Complex extracts for easing Hangover and improving liver function and preparation method of the same

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R11-asn-PN2301

St.27 status event code: A-3-3-R10-R13-asn-PN2301

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U11-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20190926

Year of fee payment: 4

PR1001 Payment of annual fee

Fee payment year number: 4

St.27 status event code: A-4-4-U10-U11-oth-PR1001

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

Fee payment year number: 5

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PR1001 Payment of annual fee

Fee payment year number: 6

St.27 status event code: A-4-4-U10-U11-oth-PR1001

PC1903 Unpaid annual fee

Not in force date: 20221018

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20221018

St.27 status event code: N-4-6-H10-H13-oth-PC1903

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

St.27 status event code: A-5-5-R10-R13-asn-PN2301